Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

JUL 02, 2015 - TheStreet

A Must Read - Share

Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point

BOSTON ( TheStreet) -- This week's Biotech Stock Mailbag is abbreviated and delivered a day early due to the Fourth of July. Happy hot dogs and fireworks, everyone!  @adamfeuerstein Let's get a halftime update! http://t.co/JPWkryFMrz #nomulligans — Joe Hetland (@joehetland) July 1, 2015 The mid-point of the year is a good time to look back to see how well I'm ...

Tags: Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point,  Pfizer Latest News

JUL 02, 2015 - Benzinga

A Must Read - Share

Icagen Re-launched Through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D

XRpro Sciences, Inc. today announced its acquisition of assets related to the ion channel biology platform from Pfizer Inc. (NYSE: PFE) that had previously been obtained as part of Pfizer's 2011 acquisition of Icagen, Inc. XRPro Sciences also acquired all of Pfizer's rights to the "Icagen" name and trademark.

Tags: Icagen Re-launched Through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D,  Pfizer Latest News

JUL 01, 2015 - TheStreet

A Must Read - Share

U.S. Companies Look to the U.K. for Investment Opportunites

NEW YORK (TheStreet) -- American businesses are increasingly looking across the Pond for opportunities to set up shop and turn a profit, according to a new study. According to a report by the UK Trade and Investment department, the United States is the largest investor in the United Kingdom for the third year in a row. The government report showed that ...

Tags: U.S. Companies Look to the U.K. for Investment Opportunites,  Pfizer Latest News

JUN 30, 2015 - TheStreet

A Must Read - Share

MannKind's Afrezza Lags Behind Biggest Failure in Inhaled Insulin

BOSTON (TheStreet) -- The number of prescriptions written for MannKind's inhaled insulin Afrezza are barely making a dent in the diabetes market five months since partner Sanofi launched the product. Afrezza is even under-performing Exubera, the first inhaled insulin launched by Pfizer in 2006. Exubera was a commercial failure, forcing Pfizer to abandon the product after one year.Here's a graphical ...

Tags: MannKind's Afrezza Lags Behind Biggest Failure in Inhaled Insulin,  Pfizer Latest News

JUN 29, 2015 - TheStreet

A Must Read - Share

3 Health Care M&A Deals and How Billionaire Investors are Playing Them

NEW YORK (TheStreet) -- The health care industry is bursting with opportunity right now, perhaps especially on the deal front. Billionaire investors aren't missing out. The U.S. Supreme Court's 6-3 ruling on Thursday rejecting a challenge to the use of federal subsidies in the Affordable Care Act wasn't just a win for President Obama. It also bodes well for the health ...

Tags: 3 Health Care M&A Deals and How Billionaire Investors are Playing Them,  Pfizer Latest News